Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SNDA · against 588 other Healthcare companies listed in US-listed
Ranked #234 of 589 · scores higher than 60% of peers
Bars: peers in each 10-point band of the valuation score75 peers with a valuation score of 30–39, including SNDA · Click a bar to see the companies
Mainly because of its earnings yield, which is weaker than most Healthcare peers.
| Metric | SNDA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | -16.7% | -4.3% | 26% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 2.5% | -0.8% | 60% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | -3.2% | -2.3% | 46% | 20% | |
| Book yieldHigher is better · 587 reported | 54.2% | 25.9% | 76% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 234 | 1.5B USD | 39 | 63 | |
| 234 | 9.4B USD | 39 | 70 | |
| 234 | 2.6B USD | 39 | 32 | |
| 234 | 354M USD | 39 | 41 | |
| 234 | 1.6B USD | 39 | 43 | |
| 239 | 4.0B USD | 38 | 56 | |
| 239 | 1.6B USD | 38 | 33 | |
| 239 | 2.0B USD | 38 | 27 | |
| 239 | 1.2B USD | 38 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score